[1]
WHO. Sustaining the drive to overcome the global impact of neglected tropical diseases: Second WHO report on neglected diseases. Crompton DWT, Ed. 2013.
[2]
Ponte-Sucre A, Gamarro F, Dujardin J-C, et al. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. Maes L, editor. PLoS Negl Trop Dis 2017; 11: (12): e0006052.
[3]
Boraschi D, Castellano LRC, Italiani P. Editorial: Interaction of Nanomaterials with the Immune System: Role in Nanosafety and Nanomedicine. Front Immunol 2019; 8: 1688.
[4]
Wagner V, Minguez-Menendez A, Pena J, Fernandez-Prada C. Innovative solutions for the control of leishmaniases: Nanoscale drug delivery systems. Curr Pharm Des 2019; 25(14): 1582-92.
[5]
Rodríguez-Carlos A, Martinez-Gutierrez F, Torres-Juarez F, Rivas-Santiago B. Antimicrobial peptides-based nanostructured delivery systems: An approach for leishmaniasis treatment. Curr Pharm Des 2019; 25(14): 1593-603.
[6]
Gondim BLC, Oshiro-Júnior JA, Fernanandes FHA, Nóbrega FP, Castellano LRC, Medeiros ACD. Plant extracts-loaded in nanostructured drug delivery systems as alternatives for the treatment of parasitic and antimicrobial diseases. Curr Pharm Des 2019; 25(14): 1604-15.
[7]
Araújo GMF, Barros ARA, Oshiro-Junior JA, et al. Nanoemulsions loaded with Amphotericin B: Development, Characterization and Leishmanicidal Activity. Curr Pharm Des 2019; 25(14): 1616-22.
Download PDF Flyer